Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's Alaunos Therapeutics, Inc. (TCRT) position

Not anymore: Ken Griffin fully exited TCRT in Q3 2024. The position peaked at an amount we cannot price in Q2 2024.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
17K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

TCRT price vs Griffin's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q3 2024 Exited −17K −100.0% 0 Nov 14, 2024
Q2 2024 New +17K 17K Aug 14, 2024
Data through Q3 2024 · filed Nov 14, 2024
2 grouped rows from 2 quarters

More Griffin positions

Common questions

Does Ken Griffin own TCRT?

Not currently. Ken Griffin fully exited TCRT in Q3 2024, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy TCRT?

Ken Griffin first disclosed a TCRT position in Q2 2024; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell TCRT?

Yes. Ken Griffin reduced and then fully exited TCRT by Q3 2024; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of TCRT does Ken Griffin own?

None as of the latest filing: Ken Griffin has exited TCRT. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for TCRT?

Ken Griffin began building the TCRT position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.